Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697). [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the effect of boceprevir and telaprevir on the pharmacokinetics of dolutegravir in healthy adult subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Boceprevir (boceprevir)
  • Dolutegravir (dolutegravir)
  • Telaprevir (telaprevir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED